The Biosimulation Technology Market is predicted to reach US$ by 2030 from US$ 3.15 billion in 2021, and to grow at a CAGR of 13% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Product Type (Software and Services), by Application (Drug Discovery, Drug Development and Others), by End User (Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Regulatory Authorities, and Academic & Research Institutes)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Simulation Plus Inc., Dassault Systemes SA, Advanced Chemistry Development, Inc., Certara USA, Inc., In Silico Biosciences, Inc., Rhenovia Pharma Ltd., Chemical Computing Group, Inc., Physiomics PLC., Entelos Holding Corporation, Leadscope, Inc., Genedata AG, and Schrodinger Inc. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Biosimulation Technology - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Biosimulation Technology - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Biosimulation Technology - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Biosimulation Technology - ANALYSIS & FORECAST, BY REGION
North America Biosimulation Technology
1. North America Biosimulation Technology , by Country
1. US
2. Canada
1. North America Biosimulation Technology , by Product
2. North America Biosimulation Technology , by Type
3. North America Biosimulation Technology , by Gender
4. North America Biosimulation Technology , by Sales Channel
3. Europe Biosimulation Technology
1. Europe Biosimulation Technology , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Biosimulation Technology , by Product
3. Europe Biosimulation Technology , by Type
4. Europe Biosimulation Technology , by Gender
5. Europe Biosimulation Technology , by Sales Channel
4. Asia Pacific Biosimulation Technology
1. Asia Pacific Biosimulation Technology , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Biosimulation Technology , by product
3. Asia Pacific Biosimulation Technology , by Type
4. Asia Pacific Biosimulation Technology , by Gender
5. Asia Pacific Biosimulation Technology , by Sales Channel
5. Rest of the World Biosimulation Technology
1. Rest of the World Biosimulation Technology , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Biosimulation Technology , by Product
3. Rest of the World Biosimulation Technology , by Type
4. Rest of the World Biosimulation Technology , by Gender
5. Rest of the World Biosimulation Technology , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 43
Price : US$ 3285 |
Date : Nov 2024 |
Category : Telecom and IT |
Pages : 178 |
Price : US$ 3285 |
Date : Nov 2024 |
Category : Telecom and IT |
Pages : 175 |
Price : US$ 3285 |
Date : Nov 2024 |
Category : Telecom and IT |
Pages : 177 |